*0011023063
*00520190130095456.0
*007ta
*008130408s2000    xx#           000 u eng d
*00901028caa a2200253 c 4500
*019  $bk
*035  $a(EXLNZ-47BIBSYS_NETWORK)990108380904702201
*035  $a(NO-TrBIB)010838090
*035  $a010838090-47bibsys_network
*040  $aNO-TrBIB$bnob$ekatreg
*1001 $aBjøro, Kristian$0(NO-TrBIB)1029805$_110333200
*24510$aRandomized trial of IFN-A induction and ribavirin vs standard IFN-A and ribavirin for chronic HCV in perviously untreated patients$cKristian Bjøro...[et al.]
*260  $c2000
*300  $as.317A
*500  $aØvrige forfattere: Helge Bell, K.Hellum, Bjørn Myrvang, Kjell Skaug
*653  $aaker$asykehus$amedisinsk$aklinikk$_123856200
*7001 $aBell, Helge$d1946-2004$0(NO-TrBIB)90183917$_79476400
*7001 $aHellum, K.$0(NO-TrBIB)1028016$_125405700
*7001 $aMyrvang, Bjørn,$d1940-$0(NO-TrBIB)90120048$_73827300
*7001 $aSkaug, Kjell$0(NO-TrBIB)1029804$_125405800
*7730 $tHepatology (trykt utg.).$dNew York : Wiley$g32(2000)nr 4 del 2$x0270-9139$w999303747114702201$w(NO-LaBS)84945(tnr)
*901  $a80
*999  $aoai:nb.bibsys.no:990108380904702202$b2021-11-01T03:08:59Z$z990108380904702202
^